GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Capital Expenditure

Kwangdong Healthbio Co (XKRX:086220) Capital Expenditure : ₩-312.07 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Kwangdong Healthbio Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Kwangdong Healthbio Co's cash flow for capital expenditures for the six months ended in Dec. 2023 was ₩-312 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-312.07 Mil.

Kwangdong Healthbio Co Capital Expenditure Historical Data

The historical data trend for Kwangdong Healthbio Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwangdong Healthbio Co Capital Expenditure Chart

Kwangdong Healthbio Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23,423.71 -17,348.34 -794.81 -1,686.05 -312.07

Kwangdong Healthbio Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only -23,423.71 -17,348.34 -794.81 -1,686.05 -312.07

Kwangdong Healthbio Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-312.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kwangdong Healthbio Co (XKRX:086220) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Capital Expenditure
Comparable Companies
XKRX:317860 XKRX:123330 XKRX:025620 XKRX:257990 XKRX:318160 XKRX:080530 XKRX:159910 XKRX:900300 XKRX:014100 XKRX:250030 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
Bundang Suji U-Tower, 767 Sinsu-ro, 7th floor, Building A, Yongin-si, Gyeonggi-do, Suji-gu, KOR
Website
http://www.bl-healthcare.com
BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.

Kwangdong Healthbio Co (XKRX:086220) Headlines

No Headlines